Biotech venture capital roundup: Osanni Bio leads with $190M Series B
By
Image
Summary
A roundup of recent venture capital financings in the biotech sector, headlined by Osanni Bio's $190 million Series B round to fund drug candidates in ophthalmology, cardiology, and oncology. The piece also briefly covers financings for Bionyra, Serapha, Nura Bio, and Oblenio.
Source
bskyBiotech venture capital roundup: Osanni Bio leads with $190M Series Bpharmaphorum.comKey quotes
· 2 pulledOsanni Bio, has been thrust into the spotlight this week with an impressive Series B, raising $190 million
The company is also looking at potentially setting up dedicated companies to develop the assets
You might also wanna read
Sarvam raises $300M Series B at $1.5B valuation led by HCLTech and Bessemer
Sarvam, India's full-stack sovereign AI company, announced a $300 million Series B funding round led by HCLTech and Bessemer Venture Partner
sarvam.ai·10d ago
OpenRouter Raises $113M in Series B Funding Led by CapitalG
OpenRouter has raised $113 million in Series B funding. The round was led by CapitalG, with participation from NVentures, ServiceNow Venture
openrouter.ai·26d ago
Investing in Longevity: The Complexities of Aging
Investors are heavily investing in longevity-focused biotech companies, with $8.5B deployed in 2024. The complexity of aging involves multip
librariesforthefuture.bio·11mo ago
Oxide Raises $100M Series B Funding to Advance Cloud Computing Vision
Oxide has successfully raised a $100M Series B funding round, led by USIT with participation from existing investors. This funding more than
oxide.computer·11mo ago
BioTradingArena: AI Biotech Trading Benchmark with 655 Validated Catalyst Cases
BioTradingArena is a benchmark dataset for AI-driven biotech trading, containing 655 validated biotech catalyst cases with linked clinical t
biotradingarena.com·4mo ago
Oxide Computer Company Raises $200 Million Series C Funding Round
Oxide Computer Company has raised a $200 million Series C funding round, following their recent $100 million Series B. The company explains
oxide.computer·4mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.